Evidence map›Paper›PMID 38193119›Full record

ArticleBioengineering & translational medicine2024

Machine learning-directed electrical impedance tomography to predict metabolically vulnerable plaques.

Justin Chen, Shaolei Wang, Kaidong Wang, Parinaz Abiri, Zi-Yu Huang, Junyi Yin, Alejandro M Jabalera, Brian Arianpour, Mehrdad Roustaei, Enbo Zhu and 9 more

Open access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Advances in Wearable Bioimaging.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Assessment of Tail-Cutting in Frozen Albacore (Foods (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Justin ChenDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.ORCID https://orcid.org/0000-0002-0827-5872
Shaolei WangDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
Kaidong WangDivision of Cardiology, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Parinaz AbiriDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
Zi-Yu HuangDepartment of Medical Engineering California Institute of Technology Pasadena California USA.
Junyi YinDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
Alejandro M JabaleraDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
Brian ArianpourDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
Mehrdad RoustaeiDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
Enbo ZhuDivision of Cardiology, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Peng ZhaoDivision of Cardiology, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Susana CavalleroDivision of Cardiology, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Sandra Duarte-VogelDivision of Laboratory Animal Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Elena StarkDivision of Anatomy, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Yuan LuoDepartment of Medical Engineering California Institute of Technology Pasadena California USA.
Peyman BenharashDivision of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Yu-Chong TaiDepartment of Medical Engineering California Institute of Technology Pasadena California USA.
Qingyu CuiDivision of Cardiology, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA.
Tzung K HsiaiDepartment of Bioengineering, Henry Samueli School of Engineering University of California, Los Angeles Los Angeles California USA.
University of California, Los Angeles · USCalifornia Institute of Technology · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Electronica Impedance to Access Metabolically Active PlaqueR01HL118650 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSIAI, TZUNG K · 2014 to 2022
$3.3M
Intravascular Deployment of a Wirelessly Powered Micro-PacerR01HL149808 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Tzung K Hsiai · 2020 to 2026
$2.8M
Exercise-Induced Shear Stress Modulates Metabolic Pathways for Vascular Repair and ProtectionI01BX004356 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI HSIAI, TZUNG K · 2019 to 2024
–
BLRD VA I01 BX004356NHLBI NIH HHS R01 HL118650NHLBI NIH HHS R01 HL149808NIGMS NIH HHS T32 GM008042
6 · The paper itself

Abstract

The characterization of atherosclerotic plaques to predict their vulnerability to rupture remains a diagnostic challenge. Despite existing imaging modalities, none have proven their abilities to identify metabolically active oxidized low-density lipoprotein (oxLDL), a marker of plaque vulnerability. To this end, we developed a machine learning-directed electrochemical impedance spectroscopy (EIS) platform to analyze oxLDL-rich plaques, with immunohistology serving as the ground truth. We fabricated the EIS sensor by affixing a six-point microelectrode configuration onto a silicone balloon catheter and electroplating the surface with platinum black (PtB) to improve the charge transfer efficiency at the electrochemical interface. To demonstrate clinical translation, we deployed the EIS sensor to the coronary arteries of an explanted human heart from a patient undergoing heart transplant and interrogated the atherosclerotic lesions to reconstruct the 3D EIS profiles of oxLDL-rich atherosclerotic plaques in both right coronary and left descending coronary arteries. To establish effective generalization of our methods, we repeated the reconstruction and training process on the common carotid arteries of an unembalmed human cadaver specimen. Our findings indicated that our DenseNet model achieves the most reliable predictions for metabolically vulnerable plaque, yielding an accuracy of 92.59% after 100 epochs of training.

Indexed as

atherosclerosiselectrochemical impedance spectroscopymachine learningnanomaterialsoxidized low‐density lipoprotein

Identifiers

PMID38193119
PMCPMC10771559
OpenAlexW4387848551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.